23.08.2018 • News

LyondellBasell completes Schulman Acquisition

LyondellBasell has completed its $2.2 billion acquisition of plastics...
LyondellBasell has completed its $2.2 billion acquisition of plastics compounder A. Schulman, doubling the size of its plastics compounding business and widening its portfolio to add an array of compounds for use in consumer and industrial products. © LyondellBasell

LyondellBasell has completed its $2.2 billion acquisition of plastics compounder A. Schulman, doubling the size of its plastics compounding business and widening its portfolio to add an array of compounds for use in consumer and industrial products.

With Schulman, the Dutch-based, US-managed olefins and polyolefins giant will gain a berth in polyethylene compounding – up to now, its compounds have been solely polypropylene-based – and become the world's largest compounder company with 6,000 employees and annual revenue of more than $4.6 billion following integration of the Ohio company’s assets.

The deal, though relatively small in terms of the purchase price and sales added, will sharpen Lyondellbasell’s presence in the market. ”A. Schulman is a full-service provider to the compounding markets” said Bob Patel, CEO of the Texas player.

A much bigger deal may be in the offing for LyondellBasell. The group is in engaged in exclusive talks with Brazilian construction conglomerate Odebrecht about acquiring its 38.1% stake in petrochemicals giant Braskem. That company’s other major shareholder, oil group Petrobras, may also be eyeing the stake, however.

In other news, LyondellBasell has broken ground for its planned $2.4 billion propylene oxide and tertiary butyl alcohol plant in Channelview, Texas, the last step in its $5 billion Gulf Coast organic growth program. Capacity for the first product will total 470,000 t/y, the second plant will be able to produce 1 million t/y.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.